MSFT
Stock Market Today, April 14: Oracle Jumps on Expanded Bloom Energy Deal
Today, April 14, 2026, investors are weighing a huge fuel-cell power partnership and new AI tools reshaping this cloud giant’s outlook.
Motley Fool  ·  Apr 14, 2026 READ →
ORCL
Stock Market Today, April 14: Oracle Jumps on Expanded Bloom Energy Deal
Today, April 14, 2026, investors are weighing a huge fuel-cell power partnership and new AI tools reshaping this cloud giant’s outlook.
Motley Fool  ·  Apr 14, 2026 READ →
PLTR
Is It Time for Palantir Investors to Panic?
Palantir's stock is down nearly 40% from its all-time high.
Motley Fool  ·  Apr 14, 2026 READ →
GOOGL
Alphabet vs. Meta Platforms: Which Digital Advertising Giant Is the Better Buy?
One is in a better position today, while the other may be more suitable for long-term investors.
Motley Fool  ·  Apr 14, 2026 READ →
INTC
Alphabet vs. Meta Platforms: Which Digital Advertising Giant Is the Better Buy?
One is in a better position today, while the other may be more suitable for long-term investors.
Motley Fool  ·  Apr 14, 2026 READ →
NVDA
Alphabet vs. Meta Platforms: Which Digital Advertising Giant Is the Better Buy?
One is in a better position today, while the other may be more suitable for long-term investors.
Motley Fool  ·  Apr 14, 2026 READ →
GOOGL
“Every Chip Is Getting Used Instantly” — Here’s Why Google’s AI Dominance May Be Unstoppable
I’ve been following Peter Diamandis’s commentary on AI infrastructure for the better part of two years now, and his recent observation on the “Moonshots with Peter Diamandis” podcast (EP 246) is stunningly accurate. His co-host laid it out: “every chip that’s coming out is getting used instantaneously. There is not an idle memory or processing ... “Every Chip Is Getting Used Instantly” — Here’s Why Google’s AI Dominance May Be Unstoppable
24/7 Wall St.  ·  Apr 14, 2026 READ →
AMZN
“Every Chip Is Getting Used Instantly” — Here’s Why Google’s AI Dominance May Be Unstoppable
I’ve been following Peter Diamandis’s commentary on AI infrastructure for the better part of two years now, and his recent observation on the “Moonshots with Peter Diamandis” podcast (EP 246) is stunningly accurate. His co-host laid it out: “every chip that’s coming out is getting used instantaneously. There is not an idle memory or processing ... “Every Chip Is Getting Used Instantly” — Here’s Why Google’s AI Dominance May Be Unstoppable
24/7 Wall St.  ·  Apr 14, 2026 READ →
MSFT
“Every Chip Is Getting Used Instantly” — Here’s Why Google’s AI Dominance May Be Unstoppable
I’ve been following Peter Diamandis’s commentary on AI infrastructure for the better part of two years now, and his recent observation on the “Moonshots with Peter Diamandis” podcast (EP 246) is stunningly accurate. His co-host laid it out: “every chip that’s coming out is getting used instantaneously. There is not an idle memory or processing ... “Every Chip Is Getting Used Instantly” — Here’s Why Google’s AI Dominance May Be Unstoppable
24/7 Wall St.  ·  Apr 14, 2026 READ →
ORCL
“Every Chip Is Getting Used Instantly” — Here’s Why Google’s AI Dominance May Be Unstoppable
I’ve been following Peter Diamandis’s commentary on AI infrastructure for the better part of two years now, and his recent observation on the “Moonshots with Peter Diamandis” podcast (EP 246) is stunningly accurate. His co-host laid it out: “every chip that’s coming out is getting used instantaneously. There is not an idle memory or processing ... “Every Chip Is Getting Used Instantly” — Here’s Why Google’s AI Dominance May Be Unstoppable
24/7 Wall St.  ·  Apr 14, 2026 READ →
BTCUSDT
Bitcoin Halving 2028 Is Now 50% Complete
The next Bitcoin halving is now 50% complete with 105,000 blocks remaining. Block rewards will drop from 3.125 to 1.5625 BTC in April 2028.
BeInCrypto  ·  Apr 14, 2026 READ →
TMO
Are Thermo Fisher’s New Data and Proteomics Alliances Quietly Redefining TMO’s Precision-Health Narrative?
In recent weeks, Thermo Fisher Scientific has announced multiple collaborations and product launches, including data partnerships, proteomics initiatives, and new cell therapy and structural biology tools, aimed at improving clinical development and advanced research. Together, these moves deepen Thermo Fisher’s role in precision health by combining large-scale real-world data, high-throughput proteomics, and automated manufacturing solutions across the biopharma value chain. We’ll now...
Simply Wall St.  ·  Apr 14, 2026 READ →